D.E. Shaw & Co’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,859
Closed -$41.5K 4563
2025
Q1
$41.5K Sell
3,859
-44,454
-92% -$545K ﹤0.01% 4074
2024
Q4
$618K Buy
48,313
+24,682
+104% +$489K ﹤0.01% 3487
2024
Q3
$652K Buy
23,631
+3,588
+18% +$105K ﹤0.01% 3552
2024
Q2
$581K Buy
20,043
+1,363
+7% +$64.9K ﹤0.01% 3531
2024
Q1
$833K Buy
+18,680
New +$800K ﹤0.01% 3211
2023
Q2
Sell
-818
Closed -$38.6K 4414
2023
Q1
$38.6K Sell
818
-2,175
-73% -$116K ﹤0.01% 4071
2022
Q4
$208K Sell
2,993
-2,369
-44% -$235K ﹤0.01% 4236
2022
Q3
$786K Sell
5,362
-8,080
-60% -$1.09M ﹤0.01% 3758
2022
Q2
$1.75M Sell
13,442
-2,720
-17% -$278K ﹤0.01% 3185
2022
Q1
$1.63M Buy
16,162
+8,058
+99% +$976K ﹤0.01% 3506
2021
Q4
$1.25M Buy
+8,104
New +$1.81M ﹤0.01% 3752

Other funds holding LYEL